Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

07. November 2014 07:00 ET | Quelle: Vaxart, Inc.

Biota Pharmaceuticals Reports First Quarter Fiscal Year 2015 Financial Results

ATLANTA, Nov. 7, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company") today announced its financial results for the three month period ended September 30, 2014, which is...
28. Oktober 2014 16:59 ET | Quelle: Vaxart, Inc.

Biota Pharmaceuticals to Host Conference Call to Report First Quarter Financial Results on November 7, 2014

ATLANTA, Oct. 28, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) ("Biota" or the "Company") announced today that management will host a conference call on Friday, November 7, 2014...
26. September 2014 07:01 ET | Quelle: Vaxart, Inc.

Biota Pharmaceuticals Reports Fourth Quarter and Fiscal Year-End 2014 Financial Results and Corporate Update

ATLANTA, Sept. 26, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company") today announced financial results for its fourth quarter and fiscal year ended June 30, 2014, and...
26. September 2014 07:00 ET | Quelle: Vaxart, Inc.

Biota Pharmaceuticals Announces Changes to Management and Board of Directors

ATLANTA, Sept. 26, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company") today announced a number of changes to management and its board of directors that will become...
15. September 2014 16:10 ET | Quelle: Vaxart, Inc.

Biota Pharmaceuticals to Host Conference Call to Report Fourth Quarter and Year-End 2014 Financial Results on September 26, 2014

ATLANTA, Sept. 15, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) ("Biota" or the "Company") announced today that it will host a conference call on Friday, September 26, 2014 at...
04. September 2014 16:35 ET | Quelle: Vaxart, Inc.

Biota to Present Preclinical Data on RSV Compound BTA-C585 at ICAAC Meeting

ATLANTA, Sept. 4, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA), a biopharmaceutical company focused on the discovery and development of products to prevent and treat serious and...
01. August 2014 07:00 ET | Quelle: Vaxart, Inc.

Biota Reports Top-Line Data From Its Phase 2 "IGLOO" Trial of Laninamivir Octanoate

ATLANTA, Aug. 1, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company") today announced top-line data from a randomized, double-blind, placebo-controlled, parallel-arm...
28. Mai 2014 09:58 ET | Quelle: Vaxart, Inc.

Biota to Present at the Jefferies 2014 Global Healthcare Conference

ATLANTA, May 28, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company") today announced that its Executive Vice President, Dr. Joseph Patti, will present a corporate update...
08. Mai 2014 07:00 ET | Quelle: Vaxart, Inc.

Biota Provides Update on BARDA Contract for Laninamivir Octanoate

ATLANTA, May 8, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company") today announced that last night it received notice from the Department of Health and Human Services...
06. Mai 2014 16:08 ET | Quelle: Vaxart, Inc.

Biota Pharmaceuticals Reports Third Quarter 2014 Financial Results and Recent Corporate Developments

ATLANTA, May 6, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company") today announced its financial results for the three month and nine month periods ended March 31,...

Vorherige Seite